Seeing Is Believing
Currently out of the existing stock ratings of Robert Davies, 6 are a HOLD (85.71%), 1 are a BUY (14.29%).
Analyst Robert Davies works at MORGAN STANLEY with a stock forecast success ratio of 33.33% fulfilled within 14.33 days on average.
Robert Davies’s has documented 18 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 20-Oct-2023.
Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 1/17/2023. The price target of $17.38 was fulfilled within 16 days with a profit of $1.41 (8.83%) receiving and performance score of 5.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
34
5 months 4 days ago
0/2 (0%)
$15.46 (83.39%)
36.47
$15.71 (75.67%)
50.57
5 months 19 days ago
4/15 (26.67%)
$19.39 (113.52%)
137
Sell
29.84
$9.08 (43.74%)
33.99
5 months 25 days ago
3/15 (20%)
$12.41 (71.20%)
116
40.12
$19.36 (93.26%)
44.25
6 months 8 days ago
0/5 (0%)
$22.47 (127.31%)
Hold
24
$3.24 (15.61%)
28
6 months 17 days ago
4/9 (44.44%)
$6.73 (38.97%)
153
What Year was the first public recommendation made by Robert Davies?